Low Nociceptor GRK2 Prolongs Prostaglandin E<sub>2</sub>Hyperalgesia via Biased cAMP Signaling to Epac/Rap1, Protein Kinase Cε, and MEK/ERK
Niels Eijkelkamp(Utrecht University), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)
Cited by 88
Related Papers
GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
|Journal of Neuroscience|2010|106
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain
|Journal of Clinical Investigation|2013|97
CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain
|JCI Insight|2022|93